BVCF Leads Series A Round For Shanghai Drug Maker CARsgen
November 27, 2014 — 22:39 CST
This Data Is Locked!
This area is available only to Subscribers.
Shanghai-based immunotherapy firm CARsgen says it has completed an undisclosed amount of series A financing led by Shanghai-based BVCF, a growth capital-focused private equity fund... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals